Whole Earth Brands, Inc. Chief Executive Officer Albert Manzone Appointed to its Board of Directors
CHICAGO, Sept. 21, 2020 (GLOBE NEWSWIRE) — Whole Earth Brands, Inc. (the “Company” or “Whole Earth Brands”) (Nasdaq: FREE), today […]
Schultze Special Purpose Acquisition Corp. and Clever Leaves International Inc., a Large-Scale Pharmaceutical-Grade Multi-National Cannabis Operator, to Participate in SPACInsider Webinar on September 22 at 2 p.m. ET
RYE BROOK, N.Y., Sept. 21, 2020 (GLOBE NEWSWIRE) — Schultze Special Purpose Acquisition Corp. (NASDAQ: SAMA, SAMAW, and SAMAU) (“SAMA”) […]
AIR Worldwide Estimates Insured Losses for Hurricane Sally Will be Between USD 1 Billion and USD 3 Billion
Boston, Sept. 21, 2020 (GLOBE NEWSWIRE) — Catastrophe risk modeling firm AIR Worldwide estimates that industry insured losses to onshore […]
OptimizeRx Continues Webinar Series, Introducing Innovative Ideas for Transforming New Medication Launches
ROCHESTER, Mich., Sept. 21, 2020 (GLOBE NEWSWIRE) — OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for […]
BridgeBio Pharma’s Calcilytix Therapeutics Initiates Phase 2 Study Of Encaleret For Autosomal Dominant Hypocalcemia Type 1 (ADH1)
Topline proof-of-concept results in ADH1 anticipated in 2021Currently, there are no approved therapies for ADH1PALO ALTO, Calif., Sept. 21, 2020 […]
MacroGenics Announces Development Milestone Achieved in Retifanlimab (MGA012) Collaboration with Incyte
$15 Million milestone triggered by initiation of Phase 3 clinical trial in NSCLC by IncyteROCKVILLE, MD, Sept. 21, 2020 (GLOBE […]
Theratechnologies Announces Preliminary Third-Quarter Fiscal 2020 Financial Results
MONTREAL, Sept. 21, 2020 (GLOBE NEWSWIRE) — Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the […]
Crinetics Pharmaceuticals Receives Rare Pediatric Disease Designation from FDA for CRN04777 for the Treatment of Congenital Hyperinsulinism
SAN DIEGO, Sept. 21, 2020 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on […]
Precision BioSciences and SpringWorks Therapeutics Announce Clinical Collaboration to Evaluate PBCAR269A in Combination with Nirogacestat in Patients with Relapsed or Refractory Multiple Myeloma
DURHAM, N.C. and STAMFORD, Conn., Sept. 21, 2020 (GLOBE NEWSWIRE) — Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology […]
Trevena, Inc. Announces Presentations at the Virtual 2020 American College of Clinical Pharmacology Annual Meeting
—Live presentation highlighting TRV027 as a potential treatment for COVID-19 acute respiratory distress syndrome (ARDS) / abnormal clottingPosters on OLINVYK […]
